Moonshot AI, the Beijing-based artificial intelligence lab known for its Kimi assistant, is targeting a valuation of tens of billions of dollars. The startup has opened a pre-IPO round (Series G) at that figure, according to reports from TechNode and the South China Morning Post, while simultaneously dismantling its offshore structure to pave the way for a Hong Kong listing planned for the end of the year. This is no simple financial maneuver; it’s a test of how global capital perceives Chinese technology in an era of sanctions. The uncomfortable question is whether investors are betting on Moonshot’s technology or on the geopolitics surrounding Chinese labs.
Kimi K3: The asset underpinning the valuation
The trigger has not been a spectacular balance sheet, but a product: Kimi K3, the reasoning model launched just a few weeks ago. According to TechNode, investor interest intensified after its unveiling, with institutions registering commitments to participate even before the round was formalized. Rumors are circulating in the sector that Microsoft is studying the use of Kimi K3 to reduce its inference costs; if confirmed, it would turn the Chinese model into a key piece of infrastructure for one of the American cloud giants.
The paradox is evident: while Washington tightens export restrictions on advanced chips to China, American companies are eyeing Chinese open-source models with interest. Kimi K3 demonstrates that Chinese artificial intelligence can compete in performance with the best Western models even with limited access to the most advanced semiconductors. That’s the argument Moonshot is presenting to investors, and it appears to be working.
The round began this week and is expected to close by the end of August. The target valuation represents a considerable leap from its last known round and places Moonshot in a league previously occupied only by OpenAI and Anthropic in the West, and DeepSeek in China.
Moonshot AI’s dual track: Hong Kong without passing through Wall Street
The most revealing move is not the figure, but the structure. Moonshot AI is dismantling its offshore entity, a technical but deeply symbolic step that facilitates a future IPO in Hong Kong. The maneuver responds to a dual-track strategy: attracting international capital without submitting to U.S. jurisdiction, hostile to Chinese tech companies, and shielding intellectual property from Washington’s regulatory pressure.
The decision to list in Hong Kong, rather than New York or Nasdaq, is no accident. Restrictions from the U.S. Committee on Foreign Investment and repeated threats to delist Chinese companies have made Wall Street increasingly hostile territory. Hong Kong offers access to global investors without the political exposure of a U.S. listing. Unwinding the offshore structure is a public commitment to the Hong Kong route and a signal that the company prefers Asian regulatory safety over American liquidity.
The timeline is ambitious: closing the round in August and going public before the year’s end. Investors entering the Series G will have to accept a very short return horizon, unusual in a sector where valuations are typically based on long-term projections. That pressure could explain why Moonshot is accepting a valuation that seems generous for a company that has yet to demonstrate a sustainable business model.
DeepSeek: The counterpoint reshaping the board
Moonshot is not alone. According to TechNode, DeepSeek has reopened talks for a second funding round, with a potential valuation that would place it in a league similar to Moonshot’s. The talks could lead to a deal by the end of August, although terms and timing are not finalized.
The temporal coincidence is no accident. Both labs are seeking capital at the same moment, after demonstrating significant technical advances. But there’s a key difference: while Moonshot seeks international capital through Hong Kong, DeepSeek appears to be playing a more domestic game, with a valuation in RMB and a focus that prioritizes Chinese technological sovereignty.
This dynamic reveals a strategic fracture in the Chinese artificial intelligence ecosystem. Some, like Moonshot, seek integration into the global capital market; others, like DeepSeek, prefer a more autarkic path. Both strategies carry risks: the former exposes them to geopolitical tensions; the latter limits access to international capital and foreign markets.
Russian state agency TASS has also reported on these operations, but its claims should be read with caution: Moscow has an interest in presenting China as a technology pole independent of the West, and its reports do not always align with verifiable facts. What is verifiable is that both labs are capitalizing on a moment of maximum global attention on Chinese artificial intelligence, and that international investors are willing to pay considerable premiums to enter that market.
Technology valuation or geopolitical valuation?
The underlying question is whether Moonshot’s valuation reflects the real value of its technology or the price of exposure to a strategic sector amid intense geopolitical tension. The answer is likely both.
Kimi K3 has shown that Chinese labs can produce competitive models with limited resources. Microsoft’s interest, though not officially confirmed, suggests the technology has real value. On the other hand, such a high valuation for a company without a clear path to profitability is only explained by context: artificial intelligence is the technological battlefield of the 21st century, and China is one of the two protagonists.
Investors entering this round are making a double bet: that Moonshot will be one of the sector’s winners and that geopolitics will not get in the way. It’s risky, but in an environment of stagnant returns in traditional tech companies, the appeal of a Chinese AI lab with a potential Hong Kong listing is hard to ignore.
The future: A test for global capitalism
Moonshot’s round is more than a financial operation: it’s a test of how far global capitalism will go to integrate Chinese tech companies into its circuit. If the Hong Kong IPO materializes by the end of the year, it will be the first major listing of a Chinese AI lab in an international market and will set a precedent.
There remains the fundamental question: Can a Chinese AI company thrive in the global market while Washington and Beijing wage a technological war? Moonshot’s answer is yes, provided the right vehicle is chosen. Hong Kong, with its status as an international financial center under Chinese sovereignty, offers that middle ground. But the history of sanctions and restrictions suggests no haven is permanent.
What’s at stake is not just Moonshot’s future, but the model of technological globalization that will survive this decade. If the round succeeds and the IPO is completed, it will be proof that capital can flow across borders even when governments try to block it. If it fails, it will confirm that technology has become too powerful a geopolitical weapon to be left to the market. The coming months will be decisive, and the world will be watching.